Clinical Research Site

Philadelphia, Pennsylvania 19140

0 studies enrolling now · 12 studies all time

What they study most

Agitation in Patients With Dementia of the Alzheimer's Type, Agitation,Psychomotor, Alzheimer Disease, Depression, Hidradenitis Suppurativa, Major Depressive Disorder, Migraine, Pulmonary Aspergillosis, Refractory IPA, Scabies, Treatment Resistant Depression

Studies at this site

• An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) — Completed
• Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) — Stopped early
• Initiating Early Control of Migraine Pain and Associated Symptoms — Completed
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) — Completed
• Hidradenitis Suppurativa Phase 2b Study of Izokibep — Completed
• Assessing Clinical Outcomes in Alzheimer's Disease Agitation — Completed
• Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed